Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Department of Health and Human Services ▸ National Institutes of Health
Description
Purpose: Helps move proven discoveries in arthritis, musculoskeletal, or skin diseases out of academic/non-profit labs and into the marketplace by funding small businesses to complete late-stage translational work.
Sponsor/Mechanism: NIH/NIAMS Small Business Innovation Research (SBIR) program using R43 (Phase I) and R44 (Phase II). Clinical trials are not allowed under this funding opportunity.
Who should apply: US small businesses (alone or teamed wi…
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Source
Grant ID
PAR-23-032
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
Awards & Funding
Award Ceiling
$350,000
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Notice of Funding Opportunity for Small Business Innovation Research (SBIR) Grant Applications
- Notice of Special Interest (NOSI): SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission
- PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)